Applied Therapeutics Inc.
(APLT)
undefined
undefined%
At close: undefined
0.90
2.94%
Pre-market Jan 07, 2025, 05:30 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -119.76M | -82.51M | -105.58M | -93.96M | -45.51M | -16.52M | -4.28M |
| Depreciation & Amortization | 354.00K | 443.00K | 415.00K | 380.00K | 23.00K | n/a | n/a |
| Stock-Based Compensation | 7.36M | 9.60M | 11.18M | 8.03M | 6.17M | 272.00K | 32.00K |
| Other Working Capital | 1.35M | -3.92M | -5.15M | 13.20M | -2.52M | -238.00K | 70.00K |
| Other Non-Cash Items | 58.32M | 3.65M | -404.00K | -360.00K | -218.00K | 3.00M | 486.00K |
| Deferred Income Tax | n/a | n/a | n/a | 2.55M | n/a | n/a | n/a |
| Change in Working Capital | -1.44M | -8.84M | 3.67M | 5.15M | 3.23M | 2.06M | 569.00K |
| Operating Cash Flow | -55.17M | -78.09M | -90.73M | -78.21M | -36.31M | -11.18M | -3.19M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -64.22M | -121.59M | -134.66M | -20.01M | n/a | n/a |
| Sales Maturities Of Investments | 13.87M | 77.39M | 134.02M | 115.19M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 13.17M | 12.43M | -19.47M | -20.01M | n/a | n/a |
| Investing Cash Flow | 13.87M | 13.17M | 12.43M | -19.47M | -20.01M | n/a | n/a |
| Debt Repayment | -1.86M | -3.27M | -4.72M | -2.15M | n/a | 5.56M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 11.89M | 3.15M | 5.01M | 4.34M | 5.95M | 21.09M | 6.47M |
| Financial Cash Flow | 74.54M | 27.69M | 74.72M | 136.29M | 56.41M | 26.65M | 6.47M |
| Net Cash Flow | 33.24M | -37.23M | -3.58M | 38.62M | 102.00K | 15.47M | 3.27M |
| Free Cash Flow | -55.17M | -78.09M | -90.73M | -78.21M | -36.31M | -11.18M | -3.19M |